ETF PRO AIOctober 28, 2026
PPH VanEck Pharmaceutical ETF
Fund tearsheet · data as of the latest session · October 28, 2026
ONE YEAR OF DAILY CLOSES
0.36%expense ratio
$1.1Bfund assets
+11.1%return, YTD
+23.9%return, 1 year
−$18Mnet flow, 1 month
−$401Mnet flow, 1 year
18.4%realized volatility, 1y
-11.5%worst drawdown, 1y
Top ten holdings
| 1 | LLY ELI LILLY | 21.80% |
| 2 | MRK MERCK & CO | 12.28% |
| 3 | NVO NOVO NORDISK A S | 5.51% |
| 4 | PFE PFIZER | 5.14% |
| 5 | MCK MCKESSON | 4.80% |
| 6 | TEVA TEVA PHARMACEUTICAL | 4.57% |
| 7 | BMY BRISTOL MYERS SQUIBB | 4.58% |
| 8 | GSK GSK | 4.53% |
| 9 | COR CENCORA INC | 4.40% |
| 10 | HLN HALEON | 3.99% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS